Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Jun
22
2021
Court Sides with Drug Manufacturers in Ongoing 340B Litigation Foley & Lardner LLP
Jun
27
2018
New Connecticut Law Allows Telemedicine Prescribing of Controlled Substances Foley & Lardner LLP
Oct
21
2021
OTC Hearing Aids: FDA Paves the Way in its Proposed Rule Foley & Lardner LLP
Dec
21
2021
Group Health Plans Subject to New Prescription Drug and Health Care Spending Reporting Requirements Foley & Lardner LLP
Jan
14
2019
American Telemedicine Association Letter Offers Recommendations on DEA Special Registration for Telemedicine Prescribing of Controlled Substances Foley & Lardner LLP
Jun
7
2022
June 2022 Food and Beverage Review: Real Estate Foley & Lardner LLP
Jun
27
2022
Three Considerations for Health Care Providers After the Dobbs Decision Foley & Lardner LLP
Jul
7
2022
What’s Next in Washington? - July Edition Foley & Lardner LLP
Jun
4
2015
Federal Circuit Hears Oral Arguments in Neupogen Biosimilar Case Foley & Lardner LLP
Nov
30
2022
HHS Proposes to Align Federal Substance Use Disorder Law with HIPAA Foley & Lardner LLP
Oct
19
2015
D.C. Court Strikes Down 340B Orphan Drug Rule Again: Will This Impact the “Mega Guidance”? Foley & Lardner LLP
Feb
11
2016
Remicade Biosimilar Closer To Approval, But Patent Dance Goes On Foley & Lardner LLP
May
16
2023
Supreme Court Won’t Hear Skinny Label Case Foley & Lardner LLP
Mar
29
2016
Four Distinct Federal and State Policies Addressing Prescription Opioid Abuse Foley & Lardner LLP
Apr
2
2020
Doctor Fraud: False Claims and Controlled Substances an Ongoing Problem for the Medical Industry Stark & Stark
Feb
2
2018
Incretin Mimetics Cases See Signs of New Life on Appeal Stark & Stark
Apr
19
2018
The Juul of Teen Nicotine Addiction Stark & Stark
Oct
6
2018
The New Jersey Supreme Court’s Latest Decision Affecting Pharmaceutical Multicounty Litigation Stark & Stark
Feb
7
2019
E-Cigarette Explosion Kills Texas Man Stark & Stark
May
30
2019
NJ Continues to Restrict Craft Breweries – Limits on Special Events, Food, & More Stark & Stark
Mar
25
2015
When on Antibiotics in Nursing Home or Hospital Watch for Diarrhea – It Could Be C-Diff Stark & Stark
Jan
25
2016
Respiratory Problems Another Potential Hazard for E-Cigarette Users Stark & Stark
Jul
14
2020
Paragard IUD Alleged to Cause Serious Injuries Stark & Stark
Mar
15
2017
E-Cigs are Gateway to Cigarette Smoking Stark & Stark
Nov
6
2020
Anheuser-Busch Not Liable for False Advertising for Pointing Out to Consumers that Miller Lite and Coors Light Use “Corn Syrup” Stark & Stark
Jun
5
2017
FDA Issues Warning Letter to DSE Healthcare Solutions for Prostate Supplement Claims Stark & Stark
Oct
6
2017
New Evidence of Amputation Risk Impacts Invokana MDL Stark & Stark
Oct
16
2017
CNN Investigates Expanding Use of Nuedexta in Nursing Homes Stark & Stark
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins